Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ Journal of Antimicro...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
Journal of Antimicrobial Chemotherapy
Article . 2025 . Peer-reviewed
License: CC BY
Data sources: Crossref
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
PubMed Central
Other literature type . 2025
License: CC BY
Data sources: PubMed Central
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
Journal of Antimicrobial Chemotherapy
Article . 2025
License: CC BY
Data sources: Pure Amsterdam UMC
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
Lirias
Article . 2025
License: CC BY
Data sources: Lirias
versions View all 7 versions
addClaim

Classifying patients with invasive fungal disease: towards a unified case definition?

towards a unified case definition?
Authors: Ergün, M.; Bruggemann, R.J.M.; Alanio, A.; Bentvelsen, R.G.; van Dijk, Karin; Ergün, Meltem; Lagrou, Katrien; +6 Authors

Classifying patients with invasive fungal disease: towards a unified case definition?

Abstract

Abstract Management of invasive fungal disease (IFD) is increasingly challenging due to recognition of novel at-risk groups, emergence of new fungal pathogens and antifungal drug resistance. Together with the availability of new diagnostic tests and treatment modalities, robust and broadly applicable IFD case definitions are critical to support research. However, the ability to classify IFDs with the current definitions has decreased, prompting the development of new case definitions. Furthermore, current case definitions rely on a single positive test as mycological evidence, while not considering discordant evidence. We propose to explore the development of a machine learning (ML)-based IFD classification model, which uses algorithms to automatically ‘learn’ from observed data to consistently and accurately classify IFDs. Although developing and validating an ML-based IFD classification model is a significant undertaking, such an endeavour should be considered a worthwhile investment by the mycology community to standardize and reduce the ambiguity in the diagnosis of non-proven IFD.

Countries
Belgium, Netherlands
Keywords

Science & Technology, 3202 Clinical sciences, 3214 Pharmacology and pharmaceutical sciences, SDG 3 – Goede gezondheid en welzijn, Microbiology, Machine Learning, Infectious Diseases, Viewpoint, SDG 3 - Good Health and Well-being, INFECTIONS, 1108 Medical Microbiology, Humans, Pharmacology & Pharmacy, ASPERGILLOSIS, 1115 Pharmacology and Pharmaceutical Sciences, Life Sciences & Biomedicine, Algorithms, Invasive Fungal Infections, 0605 Microbiology

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    1
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
1
Average
Average
Average
Green
hybrid